Commercialized Drug Products with IP Protection

ExxPharma partners with pharmaceutical companies that seek to develop and commercialize drug products that have IP protection and/or market exclusivity. The products may comprise new chemical entities, 505(b)(2) NDA candidates and specialty generic products.

ExxPharma’s staff has over 30 years of proven combined experience in the design and development of novel formulations and manufacturing technologies including twin screw hot melt extrusion (HME) processes and other twin screw-based extrusion (TSE) processes; formulation design specific to HME/TSE technology; in-process extrudate characterization and technology transfer.

  Abuse Deterrant Formulations 

A pharmaceutical technology  company that develops proprietary drug delivery systems and manufacturing technologies that provide practical solu-tions to 

  Solubility Enhancement  

A pharmaceutical technology  company that develops proprietary drug delivery systems and manufacturing technologies that provide practical solu-tions to

A pharmaceutical technology development company that develops proprietary drug delivery systems and manufacturing technologies that provide practical solu-tions to challenging product development problems, including:

> Abuse Deterrent Formulations

 

> Solubility Enhancemnt

 

> Modified Release

 

  Modified Release  

A pharmaceutical technology company that develops proprietary drug delivery systems and manufacturing technologies that provide practical solu-tions tont.